U.S. Food and Drug Administration Approves Abilify (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
Links shared publicly online about this topic.
- 1,580total visits
U.S. Food and Drug Administration Approves Abilify (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
Abilify (aripiprazole) is used to treat irritability associated with autistic disorder in pediatric patients. Includes Abilify side effects, interactions and indications.
View full resource at drugs.com
Tags: Autism, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Drug, Children's Health, FDA, Abilify
Most Recently Shared on November 24, 2009 at 12:10 am By:
FDA Approves Abilify for Irritability Associated with Autistic Disorder in Pediatric Patients - http://bit.ly/62jJ8P
Advertisement
